IBDEI0JS ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,9624,2)
 ;;=^295204
 ;;^UTILITY(U,$J,358.3,9625,0)
 ;;=V10.43^^58^635^46
 ;;^UTILITY(U,$J,358.3,9625,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9625,1,4,0)
 ;;=4^V10.43
 ;;^UTILITY(U,$J,358.3,9625,1,5,0)
 ;;=5^H/O Ovarian Cancer
 ;;^UTILITY(U,$J,358.3,9625,2)
 ;;=^295221
 ;;^UTILITY(U,$J,358.3,9626,0)
 ;;=V10.46^^58^635^47
 ;;^UTILITY(U,$J,358.3,9626,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9626,1,4,0)
 ;;=4^V10.46
 ;;^UTILITY(U,$J,358.3,9626,1,5,0)
 ;;=5^H/O Prostate Cancer
 ;;^UTILITY(U,$J,358.3,9626,2)
 ;;=^295224
 ;;^UTILITY(U,$J,358.3,9627,0)
 ;;=V10.06^^58^635^48
 ;;^UTILITY(U,$J,358.3,9627,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9627,1,4,0)
 ;;=4^V10.06
 ;;^UTILITY(U,$J,358.3,9627,1,5,0)
 ;;=5^H/O Rectal/Anal Cancer
 ;;^UTILITY(U,$J,358.3,9627,2)
 ;;=^295208
 ;;^UTILITY(U,$J,358.3,9628,0)
 ;;=V10.52^^58^635^49
 ;;^UTILITY(U,$J,358.3,9628,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9628,1,4,0)
 ;;=4^V10.52
 ;;^UTILITY(U,$J,358.3,9628,1,5,0)
 ;;=5^H/O Renal Cancer
 ;;^UTILITY(U,$J,358.3,9628,2)
 ;;=H/o Renal Cancer^295229
 ;;^UTILITY(U,$J,358.3,9629,0)
 ;;=V10.04^^58^635^51
 ;;^UTILITY(U,$J,358.3,9629,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9629,1,4,0)
 ;;=4^V10.04
 ;;^UTILITY(U,$J,358.3,9629,1,5,0)
 ;;=5^H/O Stomach Cancer
 ;;^UTILITY(U,$J,358.3,9629,2)
 ;;=^295206
 ;;^UTILITY(U,$J,358.3,9630,0)
 ;;=V10.47^^58^635^52
 ;;^UTILITY(U,$J,358.3,9630,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9630,1,4,0)
 ;;=4^V10.47
 ;;^UTILITY(U,$J,358.3,9630,1,5,0)
 ;;=5^H/O Testicular Cancer
 ;;^UTILITY(U,$J,358.3,9630,2)
 ;;=^295225
 ;;^UTILITY(U,$J,358.3,9631,0)
 ;;=V10.83^^58^635^50
 ;;^UTILITY(U,$J,358.3,9631,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9631,1,4,0)
 ;;=4^V10.83
 ;;^UTILITY(U,$J,358.3,9631,1,5,0)
 ;;=5^H/O Skin Cancer
 ;;^UTILITY(U,$J,358.3,9631,2)
 ;;=H/O Skin Cancer^295241
 ;;^UTILITY(U,$J,358.3,9632,0)
 ;;=201.90^^58^635^60
 ;;^UTILITY(U,$J,358.3,9632,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9632,1,4,0)
 ;;=4^201.90
 ;;^UTILITY(U,$J,358.3,9632,1,5,0)
 ;;=5^Hodgkin's Lymphoma, Unpsec Type & Site
 ;;^UTILITY(U,$J,358.3,9632,2)
 ;;=^267430
 ;;^UTILITY(U,$J,358.3,9633,0)
 ;;=200.20^^58^635^64
 ;;^UTILITY(U,$J,358.3,9633,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9633,1,4,0)
 ;;=4^200.20
 ;;^UTILITY(U,$J,358.3,9633,1,5,0)
 ;;=5^Lymphoma,Burkitt's,Site Unspec
 ;;^UTILITY(U,$J,358.3,9633,2)
 ;;=^17529
 ;;^UTILITY(U,$J,358.3,9634,0)
 ;;=202.00^^58^635^66
 ;;^UTILITY(U,$J,358.3,9634,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9634,1,4,0)
 ;;=4^202.00
 ;;^UTILITY(U,$J,358.3,9634,1,5,0)
 ;;=5^Lymphoma,Low-Grade,Site Unspec
 ;;^UTILITY(U,$J,358.3,9634,2)
 ;;=^72606
 ;;^UTILITY(U,$J,358.3,9635,0)
 ;;=200.10^^58^635^65
 ;;^UTILITY(U,$J,358.3,9635,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9635,1,4,0)
 ;;=4^200.10
 ;;^UTILITY(U,$J,358.3,9635,1,5,0)
 ;;=5^Lymphoma,Int or High Grade,Site Unspec
 ;;^UTILITY(U,$J,358.3,9635,2)
 ;;=^175886
 ;;^UTILITY(U,$J,358.3,9636,0)
 ;;=203.00^^58^635^77
 ;;^UTILITY(U,$J,358.3,9636,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9636,1,4,0)
 ;;=4^203.00
 ;;^UTILITY(U,$J,358.3,9636,1,5,0)
 ;;=5^Multiple Myeloma w/o Remission
 ;;^UTILITY(U,$J,358.3,9636,2)
 ;;=^267514
 ;;^UTILITY(U,$J,358.3,9637,0)
 ;;=203.01^^58^635^79
 ;;^UTILITY(U,$J,358.3,9637,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9637,1,4,0)
 ;;=4^203.01
 ;;^UTILITY(U,$J,358.3,9637,1,5,0)
 ;;=5^Multiple Myeloma,In Remission
 ;;^UTILITY(U,$J,358.3,9637,2)
 ;;=^267515
 ;;^UTILITY(U,$J,358.3,9638,0)
 ;;=V10.21^^58^635^38
 ;;^UTILITY(U,$J,358.3,9638,1,0)
 ;;=^358.31IA^5^2
